Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis
{{output}}
We constructed a cost-effectiveness model to assess the clinical and economic value of a CDS alert program that provides pharmacogenomic (PGx) testing results, compared to no alert program in acute coronary syndrome (ACS) and atrial fibrillation (AF), from a h... ...
